• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

American adults are wary of pharmaceutical company messaging

News
Article

KFF poll finds credibility gap between drug-makers and consumers.

Credibility and cost may be two reasons why your patients aren’t taking their prescription medications.

KFF Health Tracking Poll 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs,” focused partly on the emerging trend of pharmaceuticals used to treat type 2 diabetes and expanding to the weight loss industry treating people for overweight and obesity.

KFF also asked respondents about larger issues affecting the contemporary American pharmaceutical market. Among the findings: Americans don’t entirely trust medicine-makers and a growing number of patients think there’s not enough regulation on prescription drug prices.

Here’s what else KFF found.

Related Videos
© drsampsondavis.com
© drsampsondavis.com
Mike Bannon ©CSG Partners
Mike Bannon ©CSG Partners